Wang Jian, Hegele Robert A
Schulich School of Medicine and Dentistry, University of Western Ontario and Vascular Biology Research Group, Robarts Research Institute, London, Ontario, N6A 5K8, Canada.
Lipids Health Dis. 2007 Sep 20;6:23. doi: 10.1186/1476-511X-6-23.
Mice with a deleted Gpihbp1 gene encoding glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) develop severe chylomicronemia. We screened the coding regions of the human homologue--GPIHBP1--from the genomic DNA of 160 unrelated adults with fasting chylomicronemia and plasma triglycerides >10 mmol/L, each of whom had normal sequence of the LPL and APOC2 genes.
One patient with severe type 5 hyperlipoproteinemia (MIM 144650), fasting chylomicronemia and relapsing pancreatitis resistant to standard therapy was found to be homozygous for a novel GPIHBP1 missense variant, namely G56R. This mutation was absent from the genomes of 600 control subjects and 610 patients with hyperlipidemia. The GPIHBP1 G56 residue has been conserved throughout evolution and the G56R mutation was predicted to have compromised function. Her homozygous brother also had refractory chylomicronemia and relapsing pancreatitis together with early coronary heart disease. G56R heterozygotes in the family had fasting mild hypertriglyceridemia.
Thus, a very rare GPIHBP1 missense mutation appears to be associated with severe hypertriglyceridemia and chylomicronemia.
编码糖基磷脂酰肌醇锚定的高密度脂蛋白结合蛋白1(GPI-HBP1)的Gpihbp1基因缺失的小鼠会出现严重的乳糜微粒血症。我们从160名无亲缘关系的空腹乳糜微粒血症且血浆甘油三酯>10 mmol/L的成年人的基因组DNA中筛选了人类同源基因GPIHBP1的编码区,这些人每个人的LPL和APOC2基因序列均正常。
发现一名患有严重5型高脂蛋白血症(MIM 144650)、空腹乳糜微粒血症且对标准治疗耐药的复发性胰腺炎患者,其GPIHBP1基因存在一个新的错义变异,即G56R,为纯合子。600名对照受试者和610名高脂血症患者的基因组中均未发现该突变。GPIHBP1的G56残基在整个进化过程中一直保守,预测G56R突变会损害其功能。她的纯合子哥哥也患有难治性乳糜微粒血症、复发性胰腺炎以及早期冠心病。该家族中的G56R杂合子有空腹轻度高甘油三酯血症。
因此,一种非常罕见的GPIHBP1错义突变似乎与严重的高甘油三酯血症和乳糜微粒血症有关。